AI-assisted quantification of hypothalamic atrophy in amyotrophic lateral sclerosis by convolutional neural...

Area of Science:

• Neuroimaging
• Artificial Intelligence
• Neuroanatomy

Background:

• The hypothalamus is vital for metabolic homeostasis, sleep, and temperature regulation.
• Hypothalamic volume changes are linked to neurodegenerative diseases like ALS and dementia.
• Manual MRI segmentation of the hypothalamus is time-consuming and operator-dependent, hindering large-scale studies.

Purpose of the Study:

• To develop a fully automatic deep learning approach for hypothalamic segmentation and volume quantification.
• To apply this automated method to a large dataset of ALS patients and healthy controls.
• To assess the utility of AI-driven hypothalamic analysis in identifying disease-related structural changes.

Main Methods:

• A deep convolutional neural network (CNN) with a U-Net architecture and EfficientNetB0 backbone was employed for automatic segmentation.
• The method was validated on a dataset comprising 432 ALS patients and 112 healthy controls.
• Normalized hypothalamic volumes were quantified using the automated segmentation tool.

Main Results:

• The AI approach enabled rapid, accurate hypothalamic segmentation and volume quantification.
• Automated analysis successfully reproduced known hypothalamic atrophy in ALS patients compared to controls.
• Significant group-level volume differences were detected, demonstrating the method's sensitivity.

Conclusions:

• A fast, unbiased, and publicly available AI-assisted method for hypothalamic quantification has been developed.
• This tool facilitates large-scale neuroimaging research into conditions affecting the hypothalamus.
• The method shows promise for identifying subtle structural changes in neurodegenerative diseases.